Minimal important differences for fatigue patient reported outcome measures—a systematic review
暂无分享,去创建一个
Charles Taft | Åsa Lundgren-Nilsson | Å. Lundgren-Nilsson | C. Taft | Åsa Nordin | Anna Dencker | A. Dencker | Åsa Nordin | Anna Dencker
[1] G. Bleijenberg,et al. Dimensional assessment of chronic fatigue syndrome. , 1994, Journal of psychosomatic research.
[2] D. Cella,et al. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. , 2011, Journal of clinical epidemiology.
[3] D. Osoba,et al. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials , 2011, Supportive Care in Cancer.
[4] C. Terwee,et al. Mind the MIC: large variation among populations and methods. , 2010, Journal of clinical epidemiology.
[5] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[6] D. Cella,et al. Health perceptions and clinical characteristics of relapsing-remitting multiple sclerosis patients: baseline data from an international clinical trial. , 2009, Current medical research and opinion.
[7] R. Hays,et al. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment , 2005, Hepatology.
[8] D. Osoba,et al. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] S. Mody,et al. Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference , 2007, Current medical research and opinion.
[10] P. Gascón,et al. Psychometric properties of the Perform Questionnaire: a brief scale for assessing patient perceptions of fatigue in cancer , 2010, Supportive Care in Cancer.
[11] V. Joish,et al. Validation of the sleep impact scale in patients with major depressive disorder and insomnia , 2009, Current medical research and opinion.
[12] R. Hays,et al. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. , 2008, Journal of clinical epidemiology.
[13] A. Tennant,et al. Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS) , 2013, Multiple sclerosis.
[14] J. Ware,et al. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[15] D. Cella,et al. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. , 2005, The Journal of rheumatology.
[16] N. Santanello,et al. Interpreting and reporting results based on patient-reported outcomes. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[17] J. Pope,et al. The Minimally Important Difference for Patient-reported Outcomes in Spondyloarthropathies including Pain, Fatigue, Sleep, and Health Assessment Questionnaire , 2010, The Journal of Rheumatology.
[18] W. Tierney,et al. Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease , 2003, Journal of General Internal Medicine.
[19] L. Doward,et al. Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS) , 2010, Health and quality of life outcomes.
[20] J. Beaumont,et al. Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale in Patients with Moderately to Severely Active Systemic Lupus Erythematosus, Participating in a Clinical Trial , 2011, The Journal of Rheumatology.
[21] A. Richardson,et al. Fatigue: a concept analysis. , 1996, International journal of nursing studies.
[22] E. Bruera,et al. Clinically important improvement in the intensity of fatigue in patients with advanced cancer. , 2007, Journal of palliative medicine.
[23] L. Matza,et al. The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition , 2012, Quality of Life Research.
[24] Liying Zhang,et al. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases , 2012, Supportive Care in Cancer.
[25] A. Wu,et al. Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences , 2009 .
[26] M. King. A point of minimal important difference (MID): a critique of terminology and methods , 2011, Expert review of pharmacoeconomics & outcomes research.
[27] J. Spertus,et al. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. , 2004, American heart journal.
[28] J. Pope,et al. The minimally important difference (MID) for patient-reported outcomes including pain, fatigue, sleep and the health assessment questionnaire disability index (HAQ-DI) in primary Sjögren's syndrome. , 2011, Clinical and experimental rheumatology.
[29] J. Kopec,et al. Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. , 2008, Journal of clinical epidemiology.
[30] R. Kane. The clinical significance of statistical significance. , 2008, The oncologist.
[31] G. Guyatt,et al. The minimal detectable change cannot reliably replace the minimal important difference. , 2010, Journal of clinical epidemiology.
[32] G. Guyatt,et al. Measurement Properties and Interpretability of the Chronic Respiratory Disease Questionnaire (CRQ) , 2005, COPD.
[33] L. Nail,et al. Measurement of fatigue: Determining minimally important clinical differences , 2002 .
[34] J. Cramer,et al. Defining minimally important change in QOLIE-31 scores: Estimates from three placebo-controlled lacosamide trials in patients with partial-onset seizures , 2012, Epilepsy & Behavior.
[35] P. Fayers,et al. Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma , 2010, Health and quality of life outcomes.
[36] G. R. Williams,et al. An integrated method to determine meaningful changes in health-related quality of life. , 2004, Journal of clinical epidemiology.
[37] A. Wu,et al. Evaluating clinically meaningful change on the ITP-PAQ: preliminary estimates of minimal important differences. , 2009, Current medical research and opinion.
[38] Ross D Crosby,et al. Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.
[39] M. Baron,et al. The Minimally Important Difference in Clinical Practice for Patient-centered Outcomes Including Health Assessment Questionnaire, Fatigue, Pain, Sleep, Global Visual Analog Scale, and SF-36 in Scleroderma , 2010, The Journal of Rheumatology.
[40] D. Cella,et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. , 2002, Journal of pain and symptom management.
[41] R. Hays,et al. Approaches and Recommendations for Estimating Minimally Important Differences for Health-Related Quality of Life Measures , 2005, COPD.
[42] Liying Zhang,et al. Minimal important differences in the EORTC QLQ‐C15‐PAL to determine meaningful change in palliative advanced cancer patients , 2016, Asia-Pacific journal of clinical oncology.
[43] D. Patrick,et al. Assessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfa. , 2003, European journal of cancer.
[44] M. Ward,et al. Domain-specific transition questions demonstrated higher validity than global transition questions as anchors for clinically important improvement. , 2015, Journal of clinical epidemiology.
[45] J. Browne,et al. The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research , 2014, BMJ quality & safety.
[46] J. de Vries,et al. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. , 2011, Respiratory medicine.
[47] L. Nail,et al. Fatigue and the cancer experience: the state of the knowledge. , 1994, Oncology nursing forum.
[48] D. Revicki,et al. Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[49] Liying Zhang,et al. Minimal important differences in the EORTC QLQ‐C30 in patients with advanced cancer , 2014, Asia-Pacific journal of clinical oncology.
[50] L. Whitehead,et al. The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. , 2009, Journal of pain and symptom management.
[51] D. Beaton,et al. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. , 2002, Current opinion in rheumatology.
[52] P. Tugwell,et al. Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis. , 2007, The Journal of rheumatology.
[53] Liying Zhang,et al. Minimal clinically important differences in the Edmonton symptom assessment system in patients with advanced cancer. , 2013, Journal of pain and symptom management.
[54] R. Hays,et al. The Minimally Important Difference for the Fatigue Visual Analog Scale in Patients with Rheumatoid Arthritis Followed in an Academic Clinical Practice , 2008, The Journal of Rheumatology.
[55] A. Copay,et al. Understanding the minimum clinically important difference: a review of concepts and methods. , 2007, The spine journal : official journal of the North American Spine Society.
[56] J. Fisk,et al. A novel approach to estimate the minimally important difference for the fatigue impact scale in multiple sclerosis patients , 2010, Quality of Life Research.
[57] J. Fisk,et al. The Impact of Fatigue on Patients with Multiple Sclerosis , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[58] J. Kopec,et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. , 2008, The Journal of rheumatology.
[59] Alexis Wright,et al. Clinimetrics corner: a closer look at the minimal clinically important difference (MCID) , 2012, The Journal of manual & manipulative therapy.
[60] J. Fleming,et al. Determining the minimal clinically important difference criteria for the Multidimensional Fatigue Inventory in a radiotherapy population , 2010, Supportive Care in Cancer.
[61] J. Pope,et al. The Minimally Important Difference for Patient Reported Outcomes in Systemic Lupus Erythematosus Including the HAQ-DI, Pain, Fatigue, and SF-36 , 2009, The Journal of Rheumatology.
[62] S. McKenna. Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science , 2011, BMC medicine.
[63] L. Krupp,et al. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. , 1993, The Journal of neuropsychiatry and clinical neurosciences.
[64] J. Pope,et al. Minimally Important Difference for Patient-reported Outcomes in Psoriatic Arthritis: Health Assessment Questionnaire and Pain, Fatigue, and Global Visual Analog Scales , 2010, The Journal of Rheumatology.
[65] D. Cella,et al. Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening , 2002, Quality of Life Research.
[66] W. Tierney,et al. Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease. , 2007, Health services research.